Case report: Type 1 diabetes in monozygotic quadruplets

European Journal of Human Genetics

Volumn 20, Issue 4, 2012, Pages 457-462

  Stechova, Katerina ^a   Halbhuber, Zbynek ^b   Hubackova, Miluse ^a   Kayserova, Jana ^a   Petruzelkova, Lenka ^a   Vcelakova, Jana ^a   Kolouskova, Stanislava ^a   Ulmannova, Tereza ^a   Faresjö, Maria ^c,d   Neuwirth, Ales ^e   Spisek, Radek ^a   Sediva, Anna ^a   Filipp, Dominik ^e   Sumnik, Zdenek ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b Central European Biosystems   (Czech Republic)

^c JÖNKÖPING UNIVERSITY   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

cytokine array; enteroviral infection; gene expression array; genetic predisposition to diabetes; monozygotic quadruplets; type 1 diabetes

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 27; INTERLEUKIN 9; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; PANCREAS ISLET CELL ANTIBODY; RNA; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; AUTOIMMUNITY; CASE REPORT; CYTOKINE PRODUCTION; DIABETES MELLITUS; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HLA TYPING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MONOZYGOTIC QUADRUPLETS; MULTIPLE PREGNANCY; MYELOID DENDRITIC CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SHORT TANDEM REPEAT; SIBLING; VIRUS INFECTION;

AUTOIMMUNITY; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; QUADRUPLETS; T-LYMPHOCYTES, REGULATORY;

EID: 84858335347     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.212     Document Type: Article

References (48)

1. Todd JA: Etiology of type 1 diabetes. Immunity 2010; 32: 457-467.
2. Atkinson MA, Eisenbarth GS: Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221-229.
3. Tree TI, Peakman M: Autoreactive T cells in human type 1 diabetes. Endocrinol Metab Clin North Am 2004; 33: 113-133.
4. Skowera A, Ellis RJ, Varela-Calviño R et al: CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 2008; 118: 3390-3402.
5. Willcox A, Richardson SJ, Bone AJ et al: Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009; 155: 173-181.
6. Van Belle TL, Taylor P, von Herrath MG: Mouse models for type 1 diabetes. Drug Discov Today Dis Models 2009; 6: 41-45.
7. Tang Q, Bluestone JA: Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 2006; 212: 217-237.
8. Eizirik DL, Darville MI: Beta-cell apoptosis and defense mechanisms: Lessons from type 1 diabetes. Diabetes 2001; 50 (Suppl 1): S64-S69.
9. von Herrath M: Diabetes: A virus-gene collaboration. Nature 2009; 459: 518-519.
10. Kivity S, Agmon-Levin N, Blank M et al: Infections and autoimmunity - friends or foes? Trends Immunol 2009; 30: 409-414.
11. Bach JF: The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911-920.
12. Zinkernagel RM: Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 2001; 345: 1331-1335.
13. Richardson SJ, Willcox A, Bone AJ et al: The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009; 52: 1143-1151.
14. Oikarinen S, Martiskainen M, Tauriainen S et al: Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 2011; 60: 276-279.
15. Stene LC, Oikarinen S, Hyöty H et al: Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: The Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010; 59: 3174-3180.
16. Staeva-Vieira T, Peakman M, von Herrath M: Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes. Clin Exp Immunol 2007; 148: 17-31.
17. Bingley PJ, Williams AJ, Gale EA: Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials. Diabetes Care 1999; 22: 1796-1801.
18. Achenbach P, Bonifacio E, Ziegler AG: Predicting type 1 diabetes. Curr Diab Rep 2005; 5: 98-103.
19. Cinek O, Kolousková S, Snajderova M et al: HLA class II genetic association of type 1 diabetes mellitus in Czech children. Pediatr Diabetes 2001; 2: 98-102.
20. CODIS (Combined DNA Index System), http://www.fbi.gov/about-us/lab/codis/ codis.
21. Vrabelova Z, Kolouskova S, Bohmova K et al: Protein microarray analysis as a tool for monitoring cellular autoreactivity in type 1 diabetes patients and their relatives. Pediatr Diabetes 2007; 8: 252-260.
22. Horvath R, Budinsky V, Kayserova J et al: Kinetics of dendritic cells reconstitution and costimulatory molecules expression after myeloablative allogeneic haematopoetic stem cell transplantation: Implications for the development of acute graft-versus host disease. Clin Immunol 2009; 131: 60-69.
23. Parazzini F, Villa A, Moroni S et al: The epidemiology of multiple pregnancies. Acta Genet Med Gemellol (Roma) 1994; 43: 17-23.
24. Eisenbarth GS: Molecular aspects of the etiology of type I diabetes mellitus. J Diabetes Complications 1993; 7: 142-150.
25. von Herrath M: Can we learn from viruses how to prevent type 1 diabetes?: The role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies. Diabetes 2009; 58: 2-11.
26. Notkins AL: On the track of viruses. Nature 1984; 311: 209-210.
27. Yeung WC, Rawlinson WD, Craig ME: Enterovirus infection and type 1 diabetes mellitus: Systematic review and meta-analysis of observational molecular studies. BMJ 2011; 342: D35. doi: 10.1136/bmj.d35.
28. Kawai T, Akira S: TLR signaling. Semin Immunol 2007; 19: 24-32.
29. Kawai T, Akira S: The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol 2010; 11: 373-384.
30. Seya T, Oshiumi H, Sasai M et al: TICAM-1 and TICAM-2: Toll-like receptor adapters that participate in induction of type 1 interferons. Int J Biochem Cell Biol 2005; 37: 524-529.
31. Siren J, Pirhonen J, Julkunen I et al: IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J Immunol 2005; 174: 1932-1937.
32. von Herrath MG, Dockter J, Oldstone MB: How virus induces a rapid or slow onset insulindependent diabetes mellitus in a transgenic model. Immunity 1994; 1: 231-242.
33. Kato H, Takeuchi O, Sato S et al: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441: 101-105.
34. Meylan E, Tschopp J, Karin M: Intracellular pattern recognition receptors in the host response. Nature 2006; 442: 39-44.
35. Nejentsev S, Walker N, Riches D et al: Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009; 324: 387-389.
36. Murugaiyan G, Mittal A, Lopez-Diego R et al: IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 2009; 183: 2435-2443.
37. Nowak EC, Weaver CT, Turner H et al: IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 2009; 206: 1653-1660.
38. Elyaman W, Bradshaw EM, Uyttenhove C et al: IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci USA 2009; 106: 12885-12890.
39. Vrabelova Z, Hrotekova Z, Hladikova Z et al: CD 127- and FoxP3+ expression on CD25+CD4+ T regulatory cells upon specific diabetogeneic stimulation in highrisk relatives of type 1 diabetes mellitus patients. Scand J Immunol 2008; 67: 404-410.
40. Ryden A, Stechova K, Durilova M et al: Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes. Diabetes Metab Res Rev 2009; 25: 335-343.
41. Stechova K, Bohmova K, Vrabelova Z et al: High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes. Diabetes Metab Res Rev 2007; 23: 462-471.
42. Salminen K, Sadeharju K, Lönnrot M et al: Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003; 69: 91-98.
43. HA Guideline on Enteroviral Infection, 2nd revision www.ha.org.hk/ clnguide/ev71v2.htm.
44. Stechova K, Kolar M, Blatny R et al: Healthy first degree relatives of patients with type 1 diabetes exhibit significant differences in basal gene expression pattern of immunocompetent cells compared to controls: Expression pattern as predeterminant of autoimmune diabetes. Scand J Immunol 2011; e-pub ahead of print 16 September 2011; doi: 10.1111/j.1365-3083.2011.02637.x.
45. Knip M: Pathogenesis of type 1 diabetes: Implications for incidence trends. Horm Res Paediatr 2011; 76 (Suppl 1): 57-64.
46. Redondo MJ, Yu L, Hawa M et al: Heterogeneity of type 1 diabetes. Analysis of monozygotic twins in Great Britain and the United States. Diabetologia 2001; 44: 354-362.
47. Oates NA, van Vliet J, Duffy DL et al: Increased DNA methylation at the AXIN1 gene in a monozygotic twin from a pair discordant for a caudal duplication anomaly. Am J Hum Genet 2006; 79: 155-162.
48. von Herrath MG, Fujinami RS, Whitton JL: Microorganisms and autoimmunity: Making the barren field fertile? Nat Rev Microbiol 2003; 1: 151-157.